WHO ICTRP trial
Prospective self-controlled study of allogeneic MEEK skin transplantation for…
ChiCTR2400093028 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400093028 |
|---|---|
| Public title | Prospective self-controlled study of allogeneic MEEK skin transplantation for repairing split-thickness skin donor sites in patients with extensive burns |
| Scientific title | Prospective self-controlled study of allogeneic MEEK skin transplantation for repairing split-thickness skin donor sites in patients with extensive burns |
| Primary sponsor | the 990th Hospital of the Joint Logistics Support Force |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | New Treatment Measure Clinical Study |
| Countries | China |
| Conditions | burn |
| Interventions | experimental group:allogeneic MEEK skin transplantation;control group:none |
| Registration date | Nov 27, 2024 |
| Target size | experimental group:21;control group:21 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: